Quanterix Corp (NASDAQ:QTRX) – Analysts at Leerink Swann raised their FY2020 earnings estimates for shares of Quanterix in a research report issued to clients and investors on Thursday, April 5th. Leerink Swann analyst P. Souda now forecasts that the company will post earnings of $0.42 per share for the year, up from their previous estimate of $0.41. Leerink Swann currently has a “Outperform” rating and a $27.00 target price on the stock.
Several other equities research analysts also recently weighed in on QTRX. JPMorgan Chase initiated coverage on Quanterix in a research report on Tuesday, January 2nd. They set an “overweight” rating on the stock. Cowen began coverage on Quanterix in a research report on Tuesday, January 2nd. They set an “outperform” rating on the stock. BTIG Research began coverage on Quanterix in a research report on Tuesday, January 2nd. They set a “buy” rating and a $26.00 target price on the stock. Finally, ValuEngine upgraded Quanterix from a “sell” rating to a “hold” rating in a research report on Monday, April 2nd. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $26.50.
Shares of QTRX opened at $16.11 on Friday. The stock has a market cap of $352.98 and a price-to-earnings ratio of -1.94. The company has a debt-to-equity ratio of 0.07, a quick ratio of 4.35 and a current ratio of 4.53. Quanterix has a fifty-two week low of $15.56 and a fifty-two week high of $24.81.
Large investors have recently bought and sold shares of the company. Park West Asset Management LLC purchased a new position in Quanterix in the 4th quarter valued at about $4,796,000. Platinum Investment Management Ltd. purchased a new position in Quanterix in the 4th quarter valued at about $3,757,000. Millennium Management LLC purchased a new position in Quanterix in the 4th quarter valued at about $11,014,000. Perceptive Advisors LLC purchased a new position in Quanterix in the 4th quarter valued at about $3,637,000. Finally, Goldman Sachs Group Inc. purchased a new position in Quanterix in the 4th quarter valued at about $873,000. Hedge funds and other institutional investors own 42.36% of the company’s stock.
WARNING: “FY2020 Earnings Estimate for Quanterix Corp (QTRX) Issued By Leerink Swann” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/04/07/fy2020-earnings-estimate-for-quanterix-corp-qtrx-issued-by-leerink-swann.html.
Quanterix Company Profile
Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test.
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.